NCT05184283View on ClinicalTrials.gov

Utilization of MAsS in Patients Undergoing LT for HCC

TerminatedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

November 29, 2023

Study Completion Date

November 29, 2023

Conditions
NAFLDHepatocellular CarcinomaLiver DiseasesLiver CancerCirrhosis, LiverHepatitis C
Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

Sponsors

Collaborators (1)

Amra Medical AB
All Listed Sponsors
collaborator

Amra Medical AB

INDUSTRY

lead

Columbia University

OTHER

NCT05184283 - Utilization of MAsS in Patients Undergoing LT for HCC | Biotech Hunter | Biotech Hunter